Puration Announces Plans To Produce THC Infused Beverage For Legal Canadian Recreational Marijuana Market
May 01 2018 - 9:00AM
InvestorsHub NewsWire
Dallas, TX -- May 1, 2018 -- InvestorsHub NewsWire --
Puration, Inc. (USOTC:
PURA) Today announced plans to produce a THC infused beverage
in Canada in conjunction with a previously announced pending
acquisition intended to establish a cannabis cultivation
operation for the recreational marijuana market expected to be
legalized nationwide in Canada this summer. The new THC
infused beverage will expand Puration’s current cannabis infused
beverage business. Last year, Puration introduced EVERx, a
CBD infused sports water. The sales of EVERx yielded over a
60% gross margin as reported in the company’s 2017 annual report.
The initial sales have won the interest of additional distributors
to include a recently announced national distribution contract.
Puration has designed a THC infused beverage and registered the
name THCSavor. Package design is underway. Highlights
of the THCSavor go-to-market plan are to be included in the
upcoming shareholder presentation scheduled for, Thursday next
week, on May 10th, to provide overall details on the
Canadian business acquisition expected to be closed as early as the
end of this week.
For more information on Puration,
visit http://www.aciconglomerated.com.
Disclaimer/Safe
Harbor:
This news release contains
forward-looking statements within the meaning of the Securities
Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and
uncertainties. Among others, these risks include the expectation
that any of the companies mentioned herein will achieve significant
sales, the failure to meet schedule or performance requirements of
the companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024